Mesna is also used to reduce hemorrhagic cystitis induced by cyclophosphamide
No peer-reviewed human RCT has yet validated a subcutaneous dose in people as of 2026 [5][6]
Lancet 390:600612 Sharaf M, Ghaffari Sharaf M, Cetinel S, Semenchenko V, Damji KF, Unsworth LD, Montemagno C (2017) Peptides for targeting B2-crystallin fibrils
First, it acts as a potent antioxidant within cells
Due to how it helps convert and synthesize many other compounds within the body, its needed for well over 100 daily functions
At ASPN, tirzepatide is positioned as anadvanced metabolic signaling therapy, implemented selectively when dual-pathway incretin support is clinically appropriate and always within a long-term strategy focused on insulin sensitivity, metabolic signaling integrity, and sustainable outcomes